课题基金 / 基金详情

项目摘要

项目成果

Jennifer Jones的其他基金

相似基金

相关文献

中文摘要
翻译
作为一名接受过放射外科专业培训,同时接受过癌症生物学和普通免疫学研究生和博士后培训的放射肿瘤学家,我研究的最终目标是发现将免疫治疗(IT)与放射治疗(RT)相结合的有效方法,在实现肿瘤局部控制的同时促进肿瘤的全身控制。为了实现这一目标,我领导了NCI ROB颅外立体定向放射治疗(SBRT)项目的开发,并且我是ROB的主要副研究员,与Tim Greten和Austin Duffy (NCI/TGIB)合作进行NCI结肠直肠肝转移(15-C-0021)和胰腺(15-C-0027) RT + IT研究。最终,我们计划研究免疫治疗试验(如RT + IT试验、NCI VB疫苗试验和NCI的其他肿瘤免疫治疗试验)中应答者和无应答者的EV亚群,将EV亚群特征转化为可用于患者个性化和适应性治疗的生物信息。
英文摘要
As a radiation oncologist with specialized training in radiosurgery and graduate and postdoctoral training in both cancer biology and general immunology, the ultimate goal of my research is to discover effective ways to combine immunotherapies (IT) with radiation therapy (RT), to promote systemic tumor control while achieving local tumor control. Toward this goal, I led the development of the NCI ROB extracranial Stereotactic Body Radiation Therapy (SBRT) program, and I am the primary ROB Associate Investigator working with Tim Greten and Austin Duffy (NCI/TGIB) on NCI's colorectal liver metastases (15-C-0021), and pancreas (15-C-0027) RT + IT studies. Ultimately, we plan to study EV subsets in responders and non-responders from immunotherapy trials (such as these RT + IT trials, NCI VB vaccine trials, and other tumor immunotherapy trials at NCI), to translate the EV subset signatures into biological information that could be used for personalized and adaptive treatments for our patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Tumor and Treatment Response Biomarkers
  • 批准号:
    10486871
  • 项目类别:
  • 资助金额:
    $13.63万
  • 财政年份:
    --
  • 负责人:
    Jennifer Jones
  • 依托单位:
Translational Nanobiology Approaches to SARS-CoV2
  • 批准号:
    10487071
  • 项目类别:
  • 资助金额:
    $13.63万
  • 财政年份:
    --
  • 负责人:
    Jennifer Jones
  • 依托单位:
Novel Combinations of Radiation and Immunotherapy
Biophysical Characterization of EVPs and other Macromolecular Nanoparticles
  • 批准号:
    10702579
  • 项目类别:
  • 资助金额:
    $68.61万
  • 财政年份:
    --
  • 负责人:
    Jennifer Jones
  • 依托单位:
海外基金